Borussia Dortmund GmbH & Co. Kommanditgesellschaft auf Aktien (ETR:BVB)

Marinus Pharmaceuticals Balance Sheet

Financials in millions EUR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	3.12	4.36	4.5	10.57	1.73	3.32
Cash & Short-Term Investments	3.12	4.36	4.5	10.57	1.73	3.32
Cash Growth	79.78%	-3.02%	-57.47%	512.81%	-47.99%	-94.06%
Accounts Receivable	120.23	84.18	36.78	38.46	27.2	34.52
Other Receivables	-	8.19	5.6	14.12	11.54	8.93
Receivables	120.23	92.37	42.38	52.57	38.74	43.46
Inventory	8.26	5.29	5.44	4.42	6.81	6.75
Prepaid Expenses	14.72	0.59	0.58	0.79	0.54	0.6
Other Current Assets	11.66	13.8	18.2	28.21	12.9	22.38
Total Current Assets	157.98	116.41	71.11	96.55	60.72	76.51
Property, Plant & Equipment	196.08	198.27	182.25	172.45	183.45	193.04
Long-Term Investments	0.63	0.58	0.48	0.73	0.4	0.32
Other Intangible Assets	231.69	184.07	169.67	127.84	193.43	229.67
Long-Term Accounts Receivable	46.42	89.5	87.24	59.53	10.39	12.68
Other Long-Term Assets	2.13	0.86	1.08	1.33	2.09	5.72
Total Assets	634.93	589.68	511.84	458.43	450.52	517.97
Accounts Payable	114.07	106.39	86.02	75.64	64.1	67.43
Accrued Expenses	-	7.4	9.38	9.47	6.97	9.95
Short-Term Debt	-	-	-	-	56.9	8.03
Current Portion of Long-Term Debt	9.67	2.62	12.81	-	-	-
Current Portion of Leases	2.56	2.49	2.61	4.65	4.24	4.35
Current Income Taxes Payable	6.88	5.4	1.14	0	0.04	0.04
Current Unearned Revenue	38.32	20.65	23.17	19.92	5.09	3.64
Other Current Liabilities	52.58	38.03	25.9	27.57	26.26	29.17
Total Current Liabilities	224.09	182.98	161.01	137.26	163.61	122.61
Long-Term Debt	24.12	26.08	8.83	-	-	-
Long-Term Leases	9.15	9.39	10.35	12.53	16.82	20.05
Long-Term Unearned Revenue	0	-	0.01	0.02	-	0.23
Other Long-Term Liabilities	44.23	44.22	48.93	35.47	37.46	69.63
Total Liabilities	301.59	262.67	229.13	185.28	217.88	212.52
Common Stock	110.4	110.4	110.4	110.4	92	92
Additional Paid-In Capital	-	202.62	202.62	207.37	142.84	142.84
Retained Earnings	-	14.11	-30.19	-44.5	-2.09	70.72
Treasury Stock	-0.11	-0.11	-0.11	-0.11	-0.11	-0.11
Comprehensive Income & Other	223.05	-	-	-	-	-
Total Common Equity	333.34	327.01	282.71	273.16	232.64	305.45
Shareholders' Equity	333.34	327.01	282.71	273.16	232.64	305.45
Total Liabilities & Equity	634.93	589.68	511.84	458.43	450.52	517.97
Total Debt	45.5	40.58	34.59	17.18	77.96	32.44
Net Cash (Debt)	-42.38	-36.22	-30.1	-6.61	-76.24	-29.12
Net Cash Per Share	-0.39	-0.33	-0.28	-0.06	-0.83	-0.32
Filing Date Shares Outstanding	103.96	110.38	110.38	110.38	91.98	91.98
Total Common Shares Outstanding	103.96	110.38	110.38	110.38	91.98	91.98
Working Capital	-66.11	-66.57	-89.9	-40.71	-102.89	-46.1
Book Value Per Share	3.21	2.96	2.56	2.47	2.53	3.32
Tangible Book Value	101.65	142.95	113.04	145.32	39.2	75.78
Tangible Book Value Per Share	0.98	1.30	1.02	1.32	0.43	0.82
Land	-	273.68	271.79	260.2	260.22	259.87
Machinery	-	115.79	112.49	101.45	99.11	96

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.